Ms. Alexandra McMahon | Metabolomics | Best Researcher Award 

PhD Research Fellow, at University of Miami, United States.

Alexandra McMahon is a dedicated doctoral candidate in Epidemiology at the University of Miami, committed to advancing public health through molecular epidemiology and cancer research. With a strong background in microbiology and public health, she has actively contributed to NIH-funded projects focusing on breast cancer, medical cannabis, and inflammasome analyses. Alexandra’s expertise spans statistical modeling, metabolomics, and epidemiological research, making her a valuable asset in translational medicine. Her leadership in research coordination, publication writing, and conference presentations underscores her commitment to improving patient health outcomes through evidence-based interventions.

Professional Profile

Google Scholar

Education 🎓

• Doctor of Philosophy in Epidemiology, University of Miami Miller School of Medicine (2022-Present)
  • Specialized coursework: Cancer Epidemiology, Advanced Statistical Methods
• Master of Public Health in Epidemiology, University of Florida (2021-2022)
  • Specialized coursework: Epidemiology Methods I & II, Social Epidemiology
• Bachelor of Science in Microbiology and Cell Science, University of Florida (2018-2021)
  • Relevant coursework: Advanced Microbiology Lab, Biochemistry, Genetics, Python Programming

Experience 💼

• Doctoral Researcher, UM Cancer Epidemiology Research (2022-Present)
  • Leads metabolomics and inflammasome analyses for breast cancer prognosis
  • Conducts statistical modeling and develops intervention strategies
• Researcher, UF CRISP Medical Cannabis Study (2021-2023)
  • Led qualitative and quantitative studies on medical cannabis for pain management
  • Published findings in peer-reviewed journals and conferences
• Research Assistant, Health Promotion Lab (2021-2022)
  • Managed participant recruitment and data collection for NIH-funded studies
  • Trained junior research assistants in data entry and analysis

Research Interests 📝

Alexandra’s research focuses on cancer epidemiology, molecular biomarkers, and the intersection of public health and precision medicine. She explores the role of metabolomics and multi-omics in predicting breast cancer prognosis, particularly in diverse populations. Additionally, she investigates medical cannabis as a therapeutic intervention for chronic pain and its implications in inflammatory pathways. Her work contributes to developing personalized treatment strategies and improving long-term patient outcomes.

Awards & Honors 🏆

• Cancer Epidemiology Education in Special Populations Fellow, CUNY University (2023)
• University of Miami Doctoral Fellowship, Division of Epidemiology (2022-Present)
• Outstanding MPH Epidemiology Student, University of Florida (2022)
• Top Abstract Award, Cannabis Clinical Outcomes Research Conference (2022)
• Cum Laude, College of Agricultural and Life Sciences, University of Florida (2021)
• Dean’s List, University of Florida (2020)
• Phi Theta Kappa Honor Society (2018)

Top Noted Publications 📚

Medical Cannabis & Chronic Pain

1. Perceived Effectiveness of Medical Cannabis Among Adults with Chronic Pain

   • Journal: Cannabis
   • Year: 2023
   • Citations: 15
   • Summary: Examines patient-reported effectiveness of medical cannabis for chronic pain management, analyzing dosage, strain, and symptom relief.

2. Medical Marijuana Effectiveness for Chronic Pain

   • Journal: Journal of the American Geriatrics Society
   • Year: 2020
   • Citations: 25
   • Summary: Investigates the use of medical marijuana for chronic pain relief in older adults, discussing benefits, risks, and patient-reported outcomes.

Metabolomics & Breast Cancer

3. Metabolomics in Radiotherapy-Induced Early Adverse Skin Reactions of Breast Cancer Patients

   • Journal: Breast Cancer (Dove Medical Press)
   • Year: 2024
   • Citations: 10
   • Summary: Identifies metabolomic biomarkers associated with early skin toxicity in breast cancer patients undergoing radiotherapy.

4. Metabolomic Biomarkers for Breast Cancer Prognosis

   • Journal: Cancers (Under Review)
   • Year: 2024
   • Summary: Investigates metabolomic signatures that could serve as prognostic markers for breast cancer progression and treatment response.

5. Metabolomics in Radiotherapy-Induced Skin Reactions

   • Conference: Proceedings of AACR (American Association for Cancer Research)
   • Year: 2023
   • Citations: 12
   • Summary: Presents findings on metabolite changes in breast cancer patients experiencing skin reactions from radiotherapy.

6. Inflammation as a Prognostic Biomarker in Breast Cancer Patients

   • Conference: Cannabis Clinical Outcomes Research Conference
   • Year: 2023
   • Citations: 8
   • Summary: Explores inflammation-related biomarkers in breast cancer prognosis and their relationship to cannabis use.

Mental Health & Emergency Response

7. Urban Search and Rescue Mental Health Concerns
   • Conference: International Firefighter Cancer Symposium
   • Year: 2024
   • Citations: 5
   • Summary: Highlights mental health risks, PTSD, and coping mechanisms among urban search and rescue workers, with a focus on cancer risk and psychological stress.

Conclusion

Is Alexandra McMahon a strong candidate for a Best Researcher Award. Yes, she is a highly competitive candidate with a well-rounded profile, including impactful publications, funded research, leadership roles, and conference awards. With continued high-impact research, increased grant funding, and broader research scope, she could be an even stronger contender for prestigious research awards in the future.